RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BCDA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of BioCardia, Inc. stock downgraded after the last trading session.
(Updated on May 01, 2024)

Sell candidate since May 01, 2024 PDF

The BioCardia, Inc. stock price fell by -2.82% on the last day (Wednesday, 1st May 2024) from $0.387 to $0.376. During the last trading day the stock fluctuated 6.93% from a day low at $0.375 to a day high of $0.401. The price has risen in 6 of the last 10 days and is up by 2.2% over the past 2 weeks. Volume has increased on the last day by 906 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $458.24 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.347 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -15.72% during the next 3 months and, with a 90% probability hold a price between $0.293 and $0.433 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BCDA Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 4.50%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioCardia, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.376 and $0.387. A break-up above any of these levels will issue buy signals. BioCardia, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for BioCardia, Inc. stock

BioCardia, Inc. finds support from accumulated volume at $0.374 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0260 between high and low, or 6.93%. For the last week, the stock has had daily average volatility of 5.14%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCDA) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect BioCardia, Inc. to open at $0.384, and during the day (based on 14 day Average True Range), to move between $0.354 and $0.398, which gives a possible trading interval of +/-$0.0220 (+/-5.84%) up or down from last closing price. If BioCardia, Inc. takes out the full calculated possible swing range there will be an estimated 11.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.374 (0.69%) than the resistance at $0.382 (1.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

BioCardia, Inc. will release earnings BMO on Wednesday, May 08, 2024. We will update the financials statements for BioCardia, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.92% in the first trading day after earnings release.

Is BioCardia, Inc. stock A Buy?

BioCardia, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.586 Sell Candidate Downgraded

Predicted Opening Price for BioCardia, Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$0.384 ( 2.09%) $0.376

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BCDA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.410 9.00 %
R2 0.400 6.36 %
R1 0.394 4.73 %
Current price: 0.376
Support S1 0.374 -0.549 %
S2 0.368 -2.18 %
S3 0.358 -4.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.455 20.97 %
R2 0.402 6.88 %
R1 0.382 1.41 %
Current price 0.376
Support S1 0.374 -0.691%
S2 0.364 -3.19%
S3 0.360 -4.31%

FAQ

What is the symbol for BioCardia, Inc. Stock and on which exchange is it traded?
The symbol for BioCardia, Inc. is BCDA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioCardia, Inc. Stock?
BioCardia, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy BioCardia, Inc. Stock?
BioCardia, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioCardia, Inc. Stock.

What's the current price of BioCardia, Inc. Stock?
As of the end of day on the May 01, 2024, the price of an BioCardia, Inc. (BCDA) share was $0.376.

What is the 52-week high and low for BioCardia, Inc. Stock?
The 52-week high for BioCardia, Inc. Stock is $2.92 and the 52-week low is $0.346.

What is the market capitalization of BioCardia, Inc. Stock?
As of the May 01, 2024, the market capitalization of BioCardia, Inc. is 10.108M.

When is the next earnings date for BioCardia, Inc.?
The upcoming earnings date for BioCardia, Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About BioCardia, Inc.

BioCardia. BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture... BCDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT